• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. CONFORMABLE GORE TAGTHORACIC ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. CONFORMABLE GORE TAGTHORACIC ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number TGU343410
Medical Device Problem Code Fracture (1260)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 07/06/2020
Type of Reportable Event Serious Injury
Event or Problem Description
The following was reported to gore: on (b)(6) 2015, this patient underwent endovascular treatment of an thoracic aortic aneurysm using a conformable gore tag thoracic endoprosthesis.Follow up showed what appeared to be a "fractured or disconnected" gore tag device.On (b)(6) 2020, a reintervention occurred whereby the device was relined.Additional information has been requested.
 
Additional Manufacturer Narrative
H10/11: additional manufacturer narrative images were evaluated by gore imaging sciences: ¿ eight time-points were submitted for evaluation.¿ 2015, 2016, 2017, 2018 and 2019 ¿ there appears to be a single device implanted that measures ~ 10 cm in length along the outer curve.¿ diameter within the proximal end of the graft measures ~ 24 mm in 2015 and ~ 33 mm in 2016, 6/2017, 12/2017, 2018 and 2019.¿ there appears to be lack of wall apposition at the proximal end of the implanted device in 2016, 6/2017, 12/2017, 2018 and 2019.¿ (b)(6) 2020 ¿ there appears to be a disruption in wire pattern near the proximal end of the implanted device.¿ diameter within the proximal end of the graft measures ~ 24 mm in 2015 and ¿ ~ 33 mm in 2020 ¿ there appears to be lack of wall apposition at the proximal end of the implanted device.¿ there appears to be a contrast-like density present outside of the implanted device.¿ contrast cannot be confirmed with available image set, arterial phase only.¿ (b)(6) 2020 ¿ there appears to be two devices implanted, the proximal device appears to measure ~ 15 cm in length along the outer curve, the distal device appears to measure ~ 10 cm in length along the outer curve.¿ the contrast-like density visualized on cta dated (b)(6) 2020 is not visualized on the arterial phase images.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONFORMABLE GORE TAGTHORACIC ENDOPROSTHESIS
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key10359293
Report Number2017233-2020-01074
Device Sequence Number2432437
Product Code MIH
UDI-Device Identifier00733132617807
UDI-Public00733132617807
Combination Product (Y/N)N
Initial Reporter StateOR
Initial Reporter CountryUS
PMA/510(K) Number
P040043
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2015
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 01/25/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date06/30/2016
Device Model NumberTGU343410
Device Catalogue NumberTGU343410
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 07/06/2020
Supplement Date Received by Manufacturer07/06/2020
07/06/2020
Initial Report FDA Received Date08/03/2020
Supplement Report FDA Received Date11/26/2020
01/25/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age80 YR
-
-